Increasing fluoroquinolone resistance in Campylobacter jejuni, Pennsylvania, USA,1982-2001.
Fluoroquinolone-resistant Campylobacter jejuni has been observed worldwide and is now being seen in the United States. Among patients in our health-care system in Pennsylvania, fluoroquinolone-resistant C. jejuni were not observed from 1982 to 1992; however, resistance increased to 40.5% in 2001. Resistance to erythromycin remains at a low level (<5%).
Nachamkin
Irving
I
Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia 19104, USA. nachamki@mail.med.upenn.edu
Ung
Huong
H
Li
Ming
M
D000890:Anti-Infective Agents / Q000627:therapeutic use*; D016123:Campylobacter jejuni / Q000187:drug effects* / Q000472:pathogenicity; D002939:Ciprofloxacin / Q000627:therapeutic use*; D024881:Drug Resistance, Bacterial; D004917:Erythromycin / Q000627:therapeutic use*; D005759:Gastroenteritis / Q000188:drug therapy / Q000382:microbiology*; D006801:Humans; D008826:Microbial Sensitivity Tests; D010414:Pennsylvania
D000890:Anti-Infective Agents; D002939:Ciprofloxacin; D004917:Erythromycin